Dr. William Lee, MD

Media Releases

Dr. William Lee brings extensive experience, expertise, and passion for treating patients with cancer and blood disorders at ChristianaCare Oncology Hematology

Dr. William Lee, a distinguished oncologist, is in practice at Helen Graham Cancer Center, an affiliate of the group practice ChristianaCare Oncology Hematology. With an impressive background in hematology and oncology, he is committed to delivering exceptional care to patients diagnosed with a wide range of cancers and blood disorders.

A distinguished graduate of the University of California, San Francisco School of Medicine, he further honed his skills at Drexel University College of Medicine, where he completed his fellowship in Hematology and Oncology. His dedication to advancing his expertise led him to become a member of the sarcoma multidisciplinary team, specializing in the treatment of bone and connective tissue cancers, as well as a wide range of other cancer diagnoses and blood disorders.

With an unwavering commitment to his specialty, the doctor is board-certified in medical oncology and internal medicine through the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

The doctor’s commitment to patient care extends beyond his clinical practice, as he actively engages with national organizations and contributes to the field through numerous publications. His involvement in the medical community underscores his passion for continuous learning and the pursuit of excellence in the realm of Hematology and Oncology.

Dr. Lee's arrival at ChristianaCare Oncology Hematology heralds a new chapter in the center's mission to provide comprehensive, compassionate care to individuals facing cancer and blood disorders. Patients can trust in his expertise, experience, and unwavering dedication to improving outcomes and enhancing quality of life for all those under his care.

Recommended Articles

• How to Deal with Lymphoma Treatment Fatigue

  Treatment fatigue is a very common problem among lymphoma patients. Whether the patient is doing pharmaceutical treatments, chemotherapy, or other treatments, they will likely lead to fatigue and a feeling of being burnt out.This article will go over what treatment fatigue is, symptoms that are...

• Living as a Hodgkin Lymphoma Survivor: Creating a New Normal

  No one can ever truly be prepared for what it is like to live with cancer. Even the strongest survivors face setbacks, and some of the fiercest warriors share their stories of how they find their "new normals."Kimberly's storyWhen she was only 25, just five days before her wedding, Kimberly felt a...

• Survey Shows Lack of Blood Cancer Knowledge Among Americans

  If anyone is asked to describe what cancer is, chances are they’ll be able to provide at least a rough definition of the disease. Generally speaking, cancer is the name for the rapid and uncontrollable development of cells in a certain part of the body. In addition to holding a general awareness...

• How This Survivor Star Beat Hodgkin Lymphoma—Twice

  Ethan Zohn is a survivor in many ways. In 2002, he outlasted 15 fiercely strong competitors on the popular TV show, Survivor: Africa. His strength, wit, athleticism, and perseverance won him a million-dollar prize after he defeated these opponents. However, his victory was short-lived. Little did he...

• Lymphoma: The Importance of a Support System & Communication

  Regardless of what’s being said, communication is something that many people struggle with in their personal relationships. Communication requires self-awareness, listening skills, and the ability to empathize and convey thoughts and feelings accurately. When people are diagnosed with chronic...

• AstraZeneca Gains United States Approval for Lymphoma Drug

  Some forms of lymphoma are rarer than others. Most people can recognize Hodgkin lymphoma, but mantle cell lymphoma will strike them as a surprise.Because it is so rare, there are not as many drugs specific to this form of cancer. One has recently been approved in the United States, by the Food and...